Unique ID issued by UMIN | UMIN000037710 |
---|---|
Receipt number | R000043011 |
Scientific Title | The significance of Hypertriglyceridemia in life-style diseases |
Date of disclosure of the study information | 2019/08/17 |
Last modified on | 2023/08/20 11:15:58 |
The significance of Hypertriglyceridemia in life-style diseases
TG-rich study
The significance of Hypertriglyceridemia in life-style diseases
TG-rich study
Japan |
Metabolic syndrome, obesity, diabetes, hypertension, chronic kidney disease (CKD)
Medicine in general | Endocrinology and Metabolism | Nephrology |
Others
YES
Diagnosis and classification of dyslipidemia associated with various life-style diseases and exploratory research for the elucidation of molecular mechanism for the progression of atherosclerosis.
Others
Identification of disease mechanism for the development of dyslipidemia and atherosclerosis.
Exploratory
Explanatory
Not applicable
1. Diagnosis and classification of dyslipidemia.
2. Identification of mutations for the known responsible genes for the development of dyslipidemia such as LPL. APOC2, APOC3, APOA5, LMF1, GPIHBP1, GCKR, CREB3L3, GPD1.
(Since the current study is cross-sectional clinical study, there is no observation period.)
1. Measurement of HMGB1, HRG, mir-221/222, mir-335, mir-342 in serum and plasma samples.
2. Identification of unknown causal genes for development of dyslipidemia.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
1
Diagnosis
Gene | Other |
Measurement of MGB1, HRG, microRNAs (mir-221/222, mir-335, mir-342) in serum and plasma samples, and identification of mutations in dyslipidemia-related known genes such as LPL. APOC2, APOC3, APOA5, LMF1, GPIHBP1, GCKR, CREB3L3, GPD1, and other unknown genes.
20 | years-old | <= |
Not applicable |
Male and Female
The patients with metabolic syndrome, obesity, diabetes, hypertension and chronic kidney disease (CKD), who agree the paticipation in the investigation. The patients will be enrolled regardless of age, gender, out-patient and in-patient.
The patients who are judged as inappropriate for the study and who disagree the enrollment.
300
1st name | Jun |
Middle name | |
Last name | Wada |
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Department of Nephrology, Rheumatology, Endocrinology and Metabolism
700-8558
2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan
086-235-7232
junwada@okayama-u.ac.jp
1st name | Naoko |
Middle name | |
Last name | Kurooka |
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Department of Nephrology, Rheumatology, Endocrinology and Metabolism
700-8558
2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan
086-235-7235
shiropanda34@gmail.com
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Nephrology, Rheumatology, Endocrinology and Metabolism
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Nephrology, Rheumatology, Endocrinology and Metabolism
Self funding
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee
2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan
086-235-6938
mae6605@adm.okayama-u.ac.jp
NO
2019 | Year | 08 | Month | 17 | Day |
Unpublished
Open public recruiting
2019 | Year | 07 | Month | 05 | Day |
2019 | Year | 07 | Month | 05 | Day |
2019 | Year | 08 | Month | 17 | Day |
2026 | Year | 03 | Month | 31 | Day |
2019 | Year | 08 | Month | 17 | Day |
2023 | Year | 08 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043011
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |